Dr. Sulaiman Al Habib Medical Services, SA1510P1UMH1

AlAhli Capital adds to Dr. Sulaiman Al Habib Medical Services stock

Published on 10/13/2026 at 10:26 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

First-half net profit reached SAR 1.166 billion, up 2.00 percent. Dr. Sulaiman Al Habib Medical Services stock was SAR 226.20 versus SAR 210.10 low.

AlAhli Capital recommended increasing positions in Dr. Sulaiman Al Habib Medical Services on October 7, 2026.
First-half 2026 net profit reached SAR 1.166 billion, up 2.00 percent year over year.
The Tadawul stock was SAR 226.20 on October 13, 2026, with a 52-week range of SAR 210.10 to SAR 281.20.

Dr. Sulaiman Al Habib Medical Services, SA1510P1UMH1, Illustration mit AI erstellt.

Dr. Sulaiman Al Habib Medical Services (ISIN SA1510P1UMH1) received an AlAhli Capital recommendation to increase positions on October 7, 2026, according to Argaam. The recommendation gives investors a fresh reference point as the Saudi healthcare group moves toward its next reporting cycle.

Profit reached SAR 1.166 billion

In the first half of 2026, net profit reached SAR 1.166 billion, an increase of 2.00 percent from the comparable period, according to Argaam. Second-quarter profit contributed SAR 662.70 million and grew 12.00 percent, while first-quarter profit stood at SAR 503.30 million.

The sequence shows a stronger second quarter inside the half-year result. That matters because the latest reported period combines a modest half-year gain with a sharper quarterly increase, giving the recommendation a defined earnings backdrop rather than a purely technical rationale.

Three reported periods set the timeline

On February 15, 2026, fiscal-year 2025 net profit was reported at SAR 2.4015 billion, up 4.00 percent. On May 3, 2026, first-quarter profit stood at SAR 503.30 million, down 10.00 percent. On July 26, 2026, first-half profit reached SAR 1.166 billion, up 2.00 percent, according to Argaam.

What does the recommendation meet?

The recommendation meets a stock that remains valued against a wide Tadawul trading span. The October 13, 2026 quote was SAR 226.20, while the 52-week range was SAR 210.10 to SAR 281.20. The market capitalization was SAR 79.2 billion on the same date.

The group operates hospitals, specialized medical complexes, day surgery centers, pharmacies and healthcare support businesses. Its business mix also includes home healthcare, laboratories, telemedicine and technology services, according to Reuters. That breadth makes reported profit progression and facility expansion important indicators for the next company update.

Tadawul valuation sets the reference

Dr. Sulaiman Al Habib Medical Services was trading at SAR 226.20 on Tadawul on October 13, 2026 at 11:09 a.m. AST. The 52-week low was SAR 210.10 and the 52-week high was SAR 281.20, while market capitalization stood at SAR 79.2 billion.

The company is listed under ticker 4013.SR on Tadawul and the ISIN is SA1510P1UMH1, according to Global Banking and Finance. Market context: Latest market reports.